Back
Ocular Therapeutix Vs. Marinus Pharmaceuticals Industry Stock Comparison
Buy
54
OCUL
Ocular Therapeutix
Last Price:
9.05
Seasonality Move:
1.23%
Sell
47
MRNS
Marinus Pharmaceuticals
Last Price:
1.61
Seasonality Move:
6.86%
Buy
54
Ocular Therapeutix (OCUL)
is a Buy
Is Ocular Therapeutix a Buy, Sell or Hold?
- The current Ocular Therapeutix [OCUL] share price is $9.06. The Score for OCUL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- OCUL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $1.53. The Score for MRNS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- MRNS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCUL Stock Price Chart
What is Ocular Therapeutix's stock price today?
-
The Ocular Therapeutix share price today is $9.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OCUL is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $1.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing slight selling pressure.
OCUL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 60.08 | Buy |
| Chaikin Money Flow: | 844762 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.35 - 9.01) | Buy |
| Bollinger Bands (100): | (5.74 - 8.46) | Buy |
MRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 62.71 | Buy |
| Chaikin Money Flow: | -107457 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.29 - 1.49) | Buy |
| Bollinger Bands (100): | (1.26 - 1.48) | Buy |
OCUL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.7 | Buy |
| 20-day SMA: | 8.75 | Buy |
| 50-day SMA: | 8.35 | Buy |
| 200-day SMA: | 6.78 | Buy |
| 8-day EMA: | 8.79 | Buy |
| 20-day EMA: | 8.65 | Buy |
| 50-day EMA: | 8.21 | Buy |
| 200-day EMA: | 6.85 | Buy |
MRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.47 | Buy |
| 20-day SMA: | 1.43 | Buy |
| 50-day SMA: | 1.36 | Buy |
| 200-day SMA: | 5.04 | Sell |
| 8-day EMA: | 1.48 | Buy |
| 20-day EMA: | 1.43 | Buy |
| 50-day EMA: | 1.48 | Buy |
| 200-day EMA: | 3.79 | Sell |
Ocular Therapeutix Earnings Growth & OCUL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.17 per share, and an increase next year of $0.11 per share.
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.21 per share, an increase this year of $0.63 per share, and an increase next year of $0.90 per share.
Ocular Therapeutix Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Marinus Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||